Promising clinical trial results for drug for rare disease in which patients can't eat fat

In a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could also help inform better prevention methods and treatments for many types of heart disease.

Leave a Reply

Your email address will not be published. Required fields are marked *